FRANCISCO BRINGAS-JORGAN: Open Payments
NPI 1760406979 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 26 payments from 7 companies in 2025. Trend: 2023 $500 · 2024 $576 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $165 |
| Amgen Inc. | 4 | $161 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
| Lilly USA, LLC | 1 | $30 |
| ABBVIE INC. | 1 | $28 |
Products named: REPATHA, Wegovy, REXULTI, Kerendia, ABILIFY ASIMTUFII, ACCRUFER, MOUNJARO, MAVYRET.
Industry payments across CA — which companies pay providers there.
